Mioara D Manole1, Patrick M Kochanek, Ericka L Fink, Robert S B Clark. 1. Department of Pediatrics, Children's Hospital of Pittsburgh, Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, USA. mioara.manole@chp.edu
Abstract
PURPOSE OF REVIEW: The field of pediatric cardiac arrest experienced recent advances secondary to multicenter collaborations. This review summarizes developments during the last year and identifies areas for further research. RECENT FINDINGS: A large retrospective review demonstrated important differences in cause, severity, and outcome of in-hospital vs. out-of-hospital pediatric cardiac arrest. This distinction is relevant to interpretation of retrospective studies that may not distinguish between these entities, and in planning therapeutic clinical trials. Hypothermia was further evaluated as a treatment strategy after neonatal hypoxia and leaders in the field of neonatology recommend universal use of hypothermia in term neonates at risk. In infants and children after cardiac arrest, there are inadequate data to make a specific recommendation. Two retrospective studies evaluating hypothermia in children after cardiac arrest found that it tended to be administered more frequently to sicker patients. However, similar or worse outcomes of patients treated with hypothermia were observed. Use of extracorporeal membrane oxygenation is another emerging area of research in pediatric cardiac arrest, and surprisingly good outcomes have been seen with this modality in some cases. SUMMARY: Therapeutic hypothermia and extracorporeal membrane oxygenation continue to be the only treatment modalities over and above conventional care for pediatric cardiac arrest. New approaches to monitoring, treatment, and rehabilitation after cardiac arrest remain to be explored.
PURPOSE OF REVIEW: The field of pediatric cardiac arrest experienced recent advances secondary to multicenter collaborations. This review summarizes developments during the last year and identifies areas for further research. RECENT FINDINGS: A large retrospective review demonstrated important differences in cause, severity, and outcome of in-hospital vs. out-of-hospital pediatric cardiac arrest. This distinction is relevant to interpretation of retrospective studies that may not distinguish between these entities, and in planning therapeutic clinical trials. Hypothermia was further evaluated as a treatment strategy after neonatal hypoxia and leaders in the field of neonatology recommend universal use of hypothermia in term neonates at risk. In infants and children after cardiac arrest, there are inadequate data to make a specific recommendation. Two retrospective studies evaluating hypothermia in children after cardiac arrest found that it tended to be administered more frequently to sicker patients. However, similar or worse outcomes of patients treated with hypothermia were observed. Use of extracorporeal membrane oxygenation is another emerging area of research in pediatric cardiac arrest, and surprisingly good outcomes have been seen with this modality in some cases. SUMMARY: Therapeutic hypothermia and extracorporeal membrane oxygenation continue to be the only treatment modalities over and above conventional care for pediatric cardiac arrest. New approaches to monitoring, treatment, and rehabilitation after cardiac arrest remain to be explored.
Authors: Vinod H Thourani; Paul M Kirshbom; Kirk R Kanter; Janet Simsic; Brian E Kogon; Scott Wagoner; Francine Dykes; James Fortenberry; Joseph M Forbess Journal: Ann Thorac Surg Date: 2006-07 Impact factor: 4.330
Authors: Seetha Shankaran; Abbot R Laptook; Richard A Ehrenkranz; Jon E Tyson; Scott A McDonald; Edward F Donovan; Avroy A Fanaroff; W Kenneth Poole; Linda L Wright; Rosemary D Higgins; Neil N Finer; Waldemar A Carlo; Shahnaz Duara; William Oh; C Michael Cotten; David K Stevenson; Barbara J Stoll; James A Lemons; Ronnie Guillet; Alan H Jobe Journal: N Engl J Med Date: 2005-10-13 Impact factor: 91.245
Authors: Stacie B Peddy; Mary Fran Hazinski; Peter C Laussen; Ravi R Thiagarajan; George M Hoffman; Vinay Nadkarni; Sarah Tabbutt Journal: Cardiol Young Date: 2007-09 Impact factor: 1.093
Authors: Bahaaldin Alsoufi; Osman O Al-Radi; Rakan I Nazer; Colleen Gruenwald; Celeste Foreman; William G Williams; John G Coles; Christopher A Caldarone; Desmond G Bohn; Glen S Van Arsdell Journal: J Thorac Cardiovasc Surg Date: 2007-10 Impact factor: 5.209
Authors: Peter D Gluckman; John S Wyatt; Denis Azzopardi; Roberta Ballard; A David Edwards; Donna M Ferriero; Richard A Polin; Charlene M Robertson; Marianne Thoresen; Andrew Whitelaw; Alistair J Gunn Journal: Lancet Date: 2005 Feb 19-25 Impact factor: 79.321
Authors: Jiangquan Zhou; Philip E Empey; Robert R Bies; Patrick M Kochanek; Samuel M Poloyac Journal: Drug Metab Dispos Date: 2011-08-25 Impact factor: 3.922
Authors: Jerzy R Ladny; Jacek Smereka; Antonio Rodríguez-Núñez; Steve Leung; Kurt Ruetzler; Lukasz Szarpak Journal: Medicine (Baltimore) Date: 2018-02 Impact factor: 1.889
Authors: Matthew P Kirschen; Ryan W Morgan; Tanmay Majmudar; William P Landis; Tiffany Ko; Ramani Balu; Sriram Balasubramanian; Alexis Topjian; Robert M Sutton; Robert A Berg; Todd J Kilbaugh Journal: Resusc Plus Date: 2020-12-05